Global Nephroureteral Stent Market Size By Type (Sealing bracket, Closed support), By Application (Hospital, Outpatient Operating Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Nephroureteral Stent Market was valued at USD 526 million in 2023 and is expected to reach USD 874 million by 2031, expanding at a CAGR of 6.8% during the forecast period from 2023 to 2031. This market is primarily driven by the increasing incidence of urological disorders, such as kidney stones, ureteral obstructions, and strictures. The growing elderly population, advancements in stent materials and design, and rising awareness about minimally invasive urological interventions are further fueling market growth. Nephroureteral stents play a critical role in maintaining ureteral patency and ensuring the smooth drainage of urine from the kidneys to the bladder or external collection systems.

Drivers:

1. Rising Prevalence of Urological Disorders

The global burden of kidney stones, urinary tract obstructions, and related conditions is on the rise, particularly in aging populations. These health issues necessitate effective urological interventions, such as nephroureteral stents, to prevent renal damage and restore normal urinary function.

2. Advancements in Stent Design and Biocompatibility

Technological advancements have led to the development of stents with enhanced biocompatibility, flexibility, and drug-eluting properties, reducing complications like encrustation and infection, and improving patient outcomes.

3. Surge in Minimally Invasive Procedures

The increasing preference for minimally invasive surgical techniques across healthcare systems worldwide has led to higher adoption rates of nephroureteral stents, especially as part of procedures like percutaneous nephrostomy and ureteroscopy.

Restraints:

1. Risk of Stent-Related Complications

Despite their clinical benefits, nephroureteral stents can cause adverse effects such as infection, migration, hematuria, and patient discomfort, limiting their widespread use in certain patient groups.

2. High Treatment Costs in Developing Regions

The cost of diagnosis, stent placement, and follow-up procedures can be prohibitive, especially in low- and middle-income countries where reimbursement policies are less comprehensive.

Opportunity:

1. Expansion in Emerging Healthcare Markets

Emerging economies in Asia-Pacific and Latin America are witnessing significant investments in healthcare infrastructure, creating growth opportunities for nephroureteral stent manufacturers.

2. Innovations in Smart and Drug-Eluting Stents

R&D efforts focused on next-generation stents with infection-resistant coatings and controlled drug-release capabilities present untapped potential for differentiated product offerings.

Market by System Type Insights:

Based on system type, Double-J (DJ) Stents dominated the global market in 2023, owing to their widespread clinical adoption for ureteral obstructions and kidney stone management. Their simplicity, effectiveness, and adaptability across various urological conditions make them a preferred choice. The metallic and hybrid stents segment is expected to witness the highest growth rate due to increased adoption in cases requiring long-term drainage and improved durability.

Market by End-use Insights:

In terms of end-use, hospitals held the largest market share in 2023, accounting for over 60% of global revenue. This dominance is attributed to the availability of advanced urology departments, skilled professionals, and integration with diagnostic and imaging services. Ambulatory surgical centers (ASCs) are emerging as a fast-growing segment due to their cost-effectiveness, shorter wait times, and growing adoption of outpatient urological procedures.

Market by Regional Insights:

Regionally, North America dominated the market in 2023 due to its robust healthcare infrastructure, high awareness of urological health, and widespread access to advanced medical devices. However, Asia-Pacific is projected to register the fastest CAGR over the forecast period, driven by rising healthcare expenditure, increasing incidence of kidney-related ailments, and a growing base of trained urologists in countries like China and India.

Competitive Scenario:

Key players in the Global Nephroureteral Stent Market include Boston Scientific Corporation, Cook Medical, Becton, Dickinson and Company (BD), Coloplast A/S, Teleflex Incorporated, Olympus Corporation, Medline Industries, Pnn Medical A/S, Allium Medical Solutions Ltd., and UROMED Kurt Drews KG. These companies are actively engaged in product innovation, strategic mergers and acquisitions, and regional expansions.

Key Developments:

In 2023, Boston Scientific launched a next-gen hydrophilic DJ stent with enhanced comfort and durability.

In 2024, Cook Medical received regulatory approval for its novel dual-lumen nephroureteral catheter system in Europe.

In 2025, Coloplast partnered with a leading academic hospital to trial its biodegradable stent for temporary ureteral obstructions.

Scope of Work – Global Nephroureteral Stent Market

Report Metric Details

Market Size (2023) USD 526 million

Projected Market Size (2031) USD 874 million

CAGR (2023–2031) 6.8%

Market Segments By System Type, By End-Use, By Region

Growth Drivers Rising urological disorder cases, tech innovation, preference for minimally invasive procedures

Opportunities Emerging markets, smart stent innovations

FAQs:

1. What is the current market size of the Global Nephroureteral Stent Market?

The market size was valued at USD 526 million in 2023.

2. What is the major growth driver of the Global Nephroureteral Stent Market?

Rising prevalence of urological disorders and the adoption of minimally invasive interventions are key gr